These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16920030)

  • 21. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
    Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
    Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer.
    Yoon DJ; Liu CT; Quinlan DS; Nafisi PM; Kamei DT
    Ann Biomed Eng; 2011 Apr; 39(4):1235-51. PubMed ID: 21350890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human non-hematopoietic tumor cells.
    Shen X; Zhu HF; He FR; Xing W; Li L; Liu J; Yang J; Pan XF; Lei P; Wang ZH; Shen GX
    Int Immunopharmacol; 2008 Dec; 8(13-14):1813-20. PubMed ID: 18817895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active tumor-targeted delivery of PEG-protein via transferrin-transferrin-receptor system.
    Jiang Y; Tang G; Hong M; Zhu S; Fang C; Shi B; Pei Y
    J Drug Target; 2007 Dec; 15(10):672-83. PubMed ID: 18041635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding specificity and internalization properties of an antibody-avidin fusion protein targeting the human transferrin receptor.
    Rodríguez JA; Helguera G; Daniels TR; Neacato II; López-Valdés HE; Charles AC; Penichet ML
    J Control Release; 2007 Dec; 124(1-2):35-42. PubMed ID: 17884229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Targeting chemotherapy with transferrin-neocarzinostatin conjugate].
    Kohgo Y; Kato J; Sasaki K; Kondo H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1072-6. PubMed ID: 2968779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcytosis of GCSF-transferrin across rat alveolar epithelial cell monolayers.
    Widera A; Kim KJ; Crandall ED; Shen WC
    Pharm Res; 2003 Aug; 20(8):1231-8. PubMed ID: 12948021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
    Recht LD; Griffin TW; Raso V; Salimi AR
    Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transferrin conjugated poly (γ-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery.
    Zhao C; Liu X; Liu J; Yang Z; Rong X; Li M; Liang X; Wu Y
    Colloids Surf B Biointerfaces; 2014 Nov; 123():787-96. PubMed ID: 25454663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the potential of transferrin-adriamycin conjugates in the treatment of bladder cancer.
    Munns J; Yaxley J; Coomer J; Lavin MF; Gardiner RA; Watters D
    Br J Urol; 1998 Aug; 82(2):284-9. PubMed ID: 9722768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin.
    Muddineti OS; Kumari P; Ghosh B; Biswas S
    Pharm Res; 2018 Mar; 35(5):97. PubMed ID: 29541866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving the specific antitumor efficacy of ONC by fusion with N-terminal domain of transferrin.
    Qi J; Ye X; Li L; Bai H; Xu C
    Biosci Biotechnol Biochem; 2018 Jul; 82(7):1153-1158. PubMed ID: 29629632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted drug delivery to C6 glioma by transferrin-coupled liposomes.
    Eavarone DA; Yu X; Bellamkonda RV
    J Biomed Mater Res; 2000 Jul; 51(1):10-4. PubMed ID: 10813739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the defect in a variant of HL-60 promyelocytic leukemia cells with reduced transferrin receptor expression.
    Ishiguro K; Ho PT; Sartorelli AC
    Somat Cell Mol Genet; 1992 Jan; 18(1):45-63. PubMed ID: 1546369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
    Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
    Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer.
    Gao W; Ye G; Duan X; Yang X; Yang VC
    Int J Nanomedicine; 2017; 12():1047-1064. PubMed ID: 28223798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in cancer research: drug targeting without the use of monoclonal antibodies.
    Faulk WP; Harats H; McIntyre JA; Berczi A; Sun IL; Crane FL
    Am J Reprod Immunol; 1989; 21(3-4):151-4. PubMed ID: 2640441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chrono-drug delivery system based on the circadian rhythm of transferrin receptor].
    Matsunaga N; Okazaki F; Koyanagi S; Ohdo S
    Nihon Rinsho; 2013 Dec; 71(12):2200-5. PubMed ID: 24437279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folate-mediated delivery of macromolecular anticancer therapeutic agents.
    Lu Y; Low PS
    Adv Drug Deliv Rev; 2002 Sep; 54(5):675-93. PubMed ID: 12204598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.